IDiyas

For the Inventor, By the Inventor

Tokyo, Japan

Teruo Okano

USPTO Granted Patents = 34 

 

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 348(Granted Patents)


Location History:

  • Urayasu, JP (1990)
  • Chiba-ken, JP (1997 - 2002)
  • Sayama, JP (2002 - 2004)
  • Ichikawa-shi, Chiba JP (2004)
  • Shinjuku-ku Tokyo, JP (2016)
  • Shinjuku-ku, JP (2016 - 2019)
  • Tokyo, JP (1980 - 2020)

Company Filing History:

goldMedal22 out of 41 
 
Tokyo Women's Medical University
 patents
silverMedal7 out of 551 
 
Nihon Kohden Corporation
 patents
bronzeMedal3 out of 3,192 
 
Dai Nippon Printing Co., Ltd.
 patents
4. 2 out of 15 
 
Cellseed, Inc.
 patents
5. 2 out of 92 
 
Asahi Kasei Medical Co., Ltd.
 patents
6. 1 out of 1,644 
 
University of Utah Research Foundation
 patents
7. 1 out of 255 
 
Research Development Corporation of Japan
 patents
8. 1 out of 1 
 
Amersham Pharmacia Biotech K.k.
 patent
9. 1 out of 193 
 
Terumo Corporation
 patents
10. 1 out of 1 
 
Tokyo Woman's Medical University
 patent
11. 1 out of 1 
 
National University Corporation Torrori University
 patent
12. 1 out of 18 
 
Able Corporation
 patents
13. 1 out of 814 
 
Kyoto University
 patents
14. 1 out of 942 
 
Asahi Kasei Kabushiki Kaisha
 patents
15. 1 out of 20 
 
The General Corporation
 patents
16. 1 out of 8 
 
The Jikei University
 patents
17. 4 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1980-2020

Loading Chart...
Loading Chart...
34 patents (USPTO):
1. 10717961 - Cell culture system and cell culture method (2020-07-21),
2. 10688133 - Cell sheet composition for inhibiting progression of renal disorder, method of producing the same, and method of inhibiting progression of renal disorder using the same (2020-06-23),
3. 10603410 - Complex of implant and cultured periodontal ligament cell sheet, method for manufacturing the same, and method for using the same (2020-03-31),
4. 10368980 - Middle ear mucosa-like cell sheet, process of producing the same and method of using the same (2019-08-06),
5. 10251916 - Cell composition for treatment of uterine tissue and method for producing same (2019-04-09),
6. 10094816 - Method of evaluating wetting characteristic of object (2018-10-09),
7. 9950094 - Layered cell sheets containing myoblasts and method for producing same (2018-04-24),
8. 9919139 - Sheet shaped therapeutic substance transfer apparatus and method of affixing sheet shaped therapeutic substance (2018-03-20),
9. 9783773 - Cell culture apparatus (2017-10-10),
10. 9708578 - Measuring unit to be attached to cell culture container, cell culture container, and cultivation condition monitoring system (2017-07-18),
11. 9643174 - Temperature responsive adsorbent having a strong cation exchange group and method for producing the same (2017-05-09),
12. 9643173 - Temperature responsive adsorbent having a strong cation exchange group and method for producing the same (2017-05-09),
13. 9623052 - Method for producing myocardial sheet from embryonic stem cell (2017-04-18),
14. 9617519 - Method for manufacturing multilayered cell sheet, multilayered cell sheet having vascular network obtained thereby, and method of use thereof (2017-04-11),
15. 9574165 - Cell culture apparatus and cell culture method using the same (2017-02-21),

Title: Teruo Okano: Innovator in Cell Culture and Renal Disorder Solutions

Introduction

Teruo Okano is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the fields of biomedical engineering and cell culture technology. With a remarkable portfolio of 34 patents, Okano's innovations have had a substantial impact on medical practices and research.

Latest Patents

Among his latest inventions are two notable patents. The first is a sophisticated cell culture system and method. This invention encompasses a cell culture vessel, a composition-controlling fluid storage vessel, and a culture fluid composition controlling mechanism. These components work together to allow for the continuous control of fluid compositions within the cell culture environment.

The second patent focuses on a cell sheet composition designed to inhibit the progression of renal disorders. This innovative method involves applying a specialized cell sheet to parts of the kidney surface that are not covered by the fibrous capsule. The composition is designed to deliver cells capable of producing hepatocyte growth factor (HGF), a substance crucial for kidney health.

Career Highlights

Throughout his career, Okano has been associated with prestigious research institutions, including the Tokyo Women's Medical University, where he contributed to groundbreaking medical research. He also worked with Nihon Kohden Corporation, where his inventions likely advanced the company's technological capabilities in the medical field.

Collaborations

Okano has collaborated with esteemed colleagues like Tatsuya Shimizu and Masayuki Yamato, enhancing his research with their expertise. These collaborations have fostered innovative solutions to complex health issues and have been instrumental in advancing their shared fields of study.

Conclusion

Teruo Okano stands as a beacon of innovation, pushing the boundaries of cell culture technology and addressing critical health challenges through his patents and collaborative work. His contributions continue to inspire advancements in medical science and improve patient outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…